Osaic Holdings
IART icon

Osaic Holdings’s Integra LifeSciences IART Stock Holding History

Osaic Holdings’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Sell
1,420
-3,550
-71% -$49.6K ﹤0.01% 5978
2026
Q1 		$46.8K Sell
4,970
-1,193
-19% -$13.1K ﹤0.01% 5276
2025
Q4 		$76.5K Buy
6,163
+1,450
+31% +$19.3K ﹤0.01% 4934
2025
Q3 		$66.4K Buy
4,713
+594
+14% +$8.14K ﹤0.01% 5109
2025
Q2 		$51.2K Buy
4,119
+1,104
+37% +$16K ﹤0.01% 5031
2025
Q1 		$66.3K Buy
3,015
+333
+12% +$7.83K ﹤0.01% 4497
2024
Q4 		$60.8K Buy
2,682
+1,734
+183% +$37.8K ﹤0.01% 4558
2024
Q3 		$17.2K Sell
948
-144
-13% -$3.34K ﹤0.01% 5471
2024
Q2 		$31.8K Buy
1,092
+418
+62% +$12.4K ﹤0.01% 5021
2024
Q1 		$23.9K Sell
674
-507
-43% -$20.3K ﹤0.01% 5245
2023
Q4 		$51.4K Sell
1,181
-2,913
-71% -$115K ﹤0.01% 4889
2023
Q3 		$156K Sell
4,094
-2,093
-34% -$88.1K ﹤0.01% 4177
2023
Q2 		$254K Sell
6,187
-1,987
-24% -$95.6K ﹤0.01% 3710
2023
Q1 		$469K Buy
8,174
+83
+1% +$4.68K ﹤0.01% 3150
2022
Q4 		$454K Buy
8,091
+1,577
+24% +$80.3K ﹤0.01% 3108
2022
Q3 		$276K Sell
6,514
-690
-10% -$35.4K ﹤0.01% 3452
2022
Q2 		$388K Sell
7,204
-351
-5% -$21.1K ﹤0.01% 3179
2022
Q1 		$685K Buy
7,555
+381
+5% +$25.1K ﹤0.01% 2917
2021
Q4 		$479K Sell
7,174
-202
-3% -$13.7K ﹤0.01% 3104
2021
Q3 		$506K Buy
7,376
+175
+2% +$12.4K ﹤0.01% 3015
2021
Q2 		$493K Sell
7,201
-7
-0.1% -$495 ﹤0.01% 3047
2021
Q1 		$499K Sell
7,208
-1,099
-13% -$74.5K ﹤0.01% 2865
2020
Q4 		$540K Sell
8,307
-71
-0.8% -$3.82K ﹤0.01% 2570
2020
Q3 		$394K Sell
8,378
-27,323
-77% -$1.3M ﹤0.01% 2658
2020
Q2 		$1.68M Sell
35,701
-917
-3% -$45.1K 0.01% 1369
2020
Q1 		$1.63M Buy
+36,618
New +$1.92M 0.01% 1186

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Osaic Holdings's IART Position: Q2 2026 in Review

Osaic Holdings reduced its Integra LifeSciences (IART) stake by 71% in Q2 2026, selling an estimated $49.6K and leaving 1,420 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5978.

Osaic Holdings first reported a position in IART in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.68M in Q2 2020. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Osaic Holdings held 1,420 shares of Integra LifeSciences worth $25.5K as of Q2 2026.
  • Osaic Holdings sold 3,550 Integra LifeSciences shares in Q2 2026, an estimated $49.6K.
  • Integra LifeSciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5978 holding.
  • Osaic Holdings first reported a position in Integra LifeSciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Integra LifeSciences position peaked at $1.68M in Q2 2020.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.